What is Perosphere?
Perosphere operates as a specialized pharmaceutical entity focused on the optimization of existing drug delivery mechanisms to enhance safety, efficacy, and patient outcomes. The company's core competency lies in identifying market gaps where advanced delivery technology can repurpose established drugs for new medical applications. Furthermore, Perosphere is actively engaged in the development of novel chemical entities, with its lead candidate, PER977, serving as a clinical-stage anticoagulant reversal agent. This focus on high-impact, specialized therapeutics places the firm at the intersection of biotechnology innovation and clinical necessity, addressing critical needs in the anticoagulant market.
How much funding has Perosphere raised?
Perosphere has raised a total of $8.9M across 4 funding rounds:
Series A
$1M
Debt
$1.5M
Series B
$6.2M
Debt
$150K
Series A (2011): $1M, investors not publicly disclosed
Debt (2014): $1.5M led by Connecticut Innovations
Series B (2015): $6.2M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Key Investors in Perosphere
Connecticut Innovations
Connecticut Innovations is the state's strategic venture capital arm and quasipublic investment agency, providing equity and debt financing, strategic guidance, and connections to help innovative, growing companies in the state scale, with dedicated funds for sectors like AI/quantum, climate tech, and biosciences.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Perosphere?
With the infusion of this recent capital, Perosphere is well-positioned to accelerate its clinical development pipeline and refine its strategic market entry for its lead drug candidates. The company's roadmap likely involves scaling its research and development infrastructure to support the transition of PER977 through advanced clinical trials. As the firm moves into this next phase of growth, the focus will remain on securing regulatory milestones and expanding its intellectual property portfolio. By maintaining its commitment to drug delivery precision, Perosphere aims to solidify its market position, potentially attracting further institutional investment to support long-term commercialization efforts and the broader adoption of its therapeutic solutions.
See full Perosphere company page
